| abstract |
The present invention relates to a composition for use as adjunctive therapy to antitumor chemotherapeutic treatments, acquired immunodeficiency syndrome treatments and leukemia treatments. The composition consists of a mixture comprising or, preferably, consisting of a strain of bacteria Lactobacillus reuteri LRE 03 DSM 23879 which is able to strongly stimulate the production of pro¬ inflammatory cytokines (Th1) interferon INF-gamma, said cytokines exhibit a marked antiviral and/or antibacterial activity, and/or a bacterial strain Lactobacillus salivanus LS06 DSM 26037 which is able to strongly stimulate the dendritic cell production, dendritic cells exhibit a marked antiviral and/or antibacterial activity. Furthermore, said composition can comprise one or more of the following compounds: a bacterial strain being able to produce, when ingested, bacterial exopolysaccharides EPS; and/or a plant polysaccharide such as tara gum; and/or an Aloe arborescens gel; and/or a gelling agent such as sodium alginate and/or a highly bioavailable zinc internalized into a tyndallized bacterial cell. |